COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,846 Articles (22,553 medRxiv, 8,293 bioRxiv)

Most recent first Previous |  Page 2984: Articles 29831-29840  | Next

Azithromycin and ciprofloxacin have a chloroquine-like effect on respiratory epithelial cells
Deretic, V., Timmins, G. S.
10.1101/2020.03.29.008631 — Posted: 2020-03-31 Discussion: Onsite | Offsite
Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic
Boni, M. F., Lemey, P., Jiang, X., Lam, T. T.-Y., Perry, B., Castoe, T., Rambaut, A., Robertson, D. L.
10.1101/2020.03.30.015008 — Posted: 2020-03-31
A one-enzyme RT-qPCR assay for SARS-CoV-2, and procedures for reagent production
Bhadra, S., Maranhao, A. C., Ellington, A. D.
10.1101/2020.03.29.013342 — Posted: 2020-03-31
Computational Design of Peptides to Block Binding of the SARS-CoV-2 Spike Protein to Human ACE2
Huang, X., Pearce, R., Zhang, Y.
10.1101/2020.03.28.013607 — Posted: 2020-03-31
Cigarette smoke triggers the expansion of a subpopulation of respiratory epithelial cells that express the SARS-CoV-2 receptor ACE2
Smith, J. C., Sheltzer, J. M.
10.1101/2020.03.28.013672 — Posted: 2020-03-31 Discussion: Onsite
Forecasting COVID-19 impact on hospital bed-days, ICU-days, ventilator-days and deaths by US state in the next 4 months
IHME COVID-19 health service utilization forecasting team, , Murray, C. J.
10.1101/2020.03.27.20043752 — Posted: 2020-03-30 Discussion: Onsite | Offsite
A Genomic Survey of SARS-CoV-2 Reveals Multiple Introductions into Northern California without a Predominant Lineage
Deng, X., Gu, W., Federman, S., Du Plessis, L., Pybus, O., Faria, N., Wang, C., Yu, G., Pan, C.-Y., Guevara, H., Sotomayor-Gonzalez, A., Zorn, K., Gopez, A., Servellita, V., Hsu, E., Miller, S., Bedford, T., Greninger, A., Roychoudhury, P., Famulare, M., Chu, H. Y., Shendure, J., Starita, L., Anderson, C., Gangavarapu, K., Zeller, M., Spencer, E., Andersen, K., MacCannell, D., Tong, S., Armstrong, G., Paden, C., Li, Y., Zhang, Y., Morrow, S., Willis, M., Matyas, B., Mase, S., Kasirye, O., Park, M., Chan, C., Yu, A., Chai, S., Villarino, E., Bonin, B., Wadford, D., Chiu, C. Y.
10.1101/2020.03.27.20044925 — Posted: 2020-03-30 Discussion: Onsite
General Model for COVID-19 Spreading with Consideration of Intercity Migration, Insufficient Testing and Active Intervention: Application to Study of Pandemic Progression in Japan and USA
Zhan, C., Tse, C. K., Lai, Z., Chen, X., Mo, M.
10.1101/2020.03.25.20043380 — Posted: 2020-03-30
Clinical characteristics associated with COVID-19 severity in California
Rubin, S. J. S., Falkson, S. R., Degner, N., Blish, C.
10.1101/2020.03.27.20043661 — Posted: 2020-03-30
A Multi-hospital Study in Wuhan, China：Protective Effects of Non-menopause and Female Hormones on SARS-CoV-2 infection
Ding, T., Zhang, J., Wang, T., Cui, P., Chen, Z., Jiang, J., Zhou, S., Dai, J., Wang, B., Yuan, S., Ma, W., Ma, L., Rong, Y., Chang, J., Miao, X., Ma, X., Wang, S.
10.1101/2020.03.26.20043943 — Posted: 2020-03-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).